Serum and CSF glutamine levels in valproate-related hyperammonemic encephalopathy.
about
Cerebral ammonia uptake and accumulation during prolonged exercise in humansEncephalopathy in acute liver failure resulting from acetaminophen intoxication: new observations with potential therapyPronounced reversible hyperammonemic encephalopathy associated with combined valproate-topiramate therapy in a 7-year-old girl.A reversible cause of coma in epilepsyFatal Nonhepatic Hyperammonemia in ICU Setting: A Rare but Serious Complication following Bariatric Surgery.Valproic Acid-induced hyperammonemia in the elderly: a review of the literatureIdentification of abnormal neuronal metabolism outside the seizure focus in temporal lobe epilepsy.Encephalopathy in an infant with infantile spasms: possible role of valproate toxicity.Astrocyte glutamine synthetase: importance in hyperammonemic syndromes and potential target for therapyValproate-induced hyperammonaemia superimposed upon severe neuropsychiatric lupus: a case report and review of the literature.Drug-induced cerebellar ataxia: a systematic review.Sodium valproate-related hyperammonaemic encephalopathy.Ultrastructure of astrocytes in the cortex of the hippocampal gyrus and in the neocortex of the temporal lobe in experimental valproate encephalopathy and after valproate withdrawal.Valproate-induced hyperammonemic encephalopathy treated by hemodialysis.[Hyperammonemia secondary to the use of valproic acid: case report].Non-convulsive status epilepticus secondary to valproic acid-induced hyperammonemic encephalopathy.Ornithine transcarbamylase deficiency presenting with acute reversible cortical blindness.
P2860
Q24676686-814FA1E2-DA7E-40D1-83C0-59C209030560Q35387099-F0416226-2CAC-4CB4-98D5-FED07D07AF3EQ35748734-F1ECE203-712E-492A-B7AA-507A182B4DB3Q35982984-5F0B2082-9F27-4E41-A760-D46C451023C9Q36828219-391F0949-F053-486E-96B1-F38A367E6955Q37317489-09C93924-1E79-49B5-9A2B-8CD85719998BQ37348529-F6506ADF-029B-4B40-AB39-B9F99FAC5A00Q37711872-0CFEDFA8-E8EC-4116-9ACE-14075B5597AEQ37794394-AF2C76BC-B822-4C9E-9FF1-EB8914B124D8Q38070123-24DE251A-628A-4939-A4FB-DA32A4688E3CQ38267726-99AD6B01-5A21-432F-B27C-0C20F0B5194BQ38767317-835728FA-EF1F-4A3A-B18D-B11B4172EBDBQ44585274-CFD9EDC7-4924-44D1-B2ED-F028D04D44EEQ46367536-8764787F-94C9-4407-BED5-039F64FBF39FQ46650907-6FF62F45-50E8-44F7-96D8-B34C83004C13Q48091925-EBB18D11-6ABF-48D5-8A63-8D6457CF5060Q48777149-C943FBD0-8C26-4BA6-85DF-03A27FF7042E
P2860
Serum and CSF glutamine levels in valproate-related hyperammonemic encephalopathy.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
Serum and CSF glutamine levels in valproate-related hyperammonemic encephalopathy.
@en
Serum and CSF glutamine levels in valproate-related hyperammonemic encephalopathy.
@nl
type
label
Serum and CSF glutamine levels in valproate-related hyperammonemic encephalopathy.
@en
Serum and CSF glutamine levels in valproate-related hyperammonemic encephalopathy.
@nl
prefLabel
Serum and CSF glutamine levels in valproate-related hyperammonemic encephalopathy.
@en
Serum and CSF glutamine levels in valproate-related hyperammonemic encephalopathy.
@nl
P2093
P2860
P1433
P1476
Serum and CSF glutamine levels in valproate-related hyperammonemic encephalopathy.
@en
P2093
Alan J Wilensky
David F Cawthon
David G Vossler
Diana L Abson Kraemer
John D Morgan
Linda M Ojemann
Lisa M Caylor
P2860
P304
P356
10.1046/J.1528-1157.2002.25001.X
P577
2002-02-01T00:00:00Z